Records containing: Leukemia

This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.

All FDA submission records EMA medicine records ClinicalTrials.gov record updates ClinicalTrials.gov records with results posted

CLINICAL_TRIALS study record update · 2026-01-20
cfDNA Assay Multicenter Prospective Observational Validation for Early Cancer Detection, Minimal Residual Disease, and Relapse
CLINICAL_TRIALS study record update · 2026-01-16
A Phase 1, Open-label, Multicentre Study Evaluating the Safety, Tolerability, Pharmacokinetic/Pharmacodynamic Characteristics, and Preliminary Efficacy of CG009301 for Injection in Adult Subjects With Relapsed or Refractory Haematological Malignancies
CLINICAL_TRIALS study record update · 2026-01-15
Mitoxantrone for Venetoclax Resistant Acute Myeloid Leukemia
CLINICAL_TRIALS study record update · 2026-01-15
Removing Transfusion Dependence as a Barrier to Hospice Enrollment
CLINICAL_TRIALS study record update · 2026-01-07
Phase II Study of Palifermin With Leuprolide Acetate or Degarelix For the Promotion of Immune Recovery Following Total Body Irradiation Based T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation
Organize your saved records without ads with Plus.
CLINICAL_TRIALS study record update · 2026-01-07
Ascertainment of Peripheral Blood or Saliva Samples for Genetic Epidemiology Studies of Familial Cancers
CLINICAL_TRIALS study record update · 2026-01-06
Peer Support Group for AYA Allogeneic Stem Cell Transplant Recipients
CLINICAL_TRIALS study record update · 2026-01-06
Immune Reconstitution Monitoring and Pneumococcal Vaccination (PCV-21) in Patients Treated With Chimeric Antigen Receptor T-Cells
CLINICAL_TRIALS study record update · 2026-01-02
Cytokine-induced Memory-like Natural Killer Cell Therapy After Hematopoietic Stem Cell Transplantation for Eradication of Measurable Residual Disease, a Phase I/Ib Clinical Trial
CLINICAL_TRIALS study record update · 2025-12-30
Ibrutinib lead-in Followed by Venetoclax Plus Ibrutinib in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia. A Multicenter, Open-label, Phase II Trial
CLINICAL_TRIALS study record update · 2025-12-26
Efficacy and Safety of Reduced-Dose Apixaban and Rivaroxaban Versus Low-Molecular-Weight Heparin in Patients With Hematologic Malignancies: A Prospective Randomized Study
CLINICAL_TRIALS study record update · 2025-12-24
An Open Label, Non-Randomized, Multi-Center Pilot Dose-Expansion Study of Low Dose Post-Transplant Cyclophosphamide/Tacrolimus/Ruxolitinib for GVHD Prophylaxis in Myeloablative Allogeneic Peripheral Blood Stem Cell Transplantation
CLINICAL_TRIALS study record update · 2025-12-19
Tumors and Respiratory System Diseases Due to Air Pollution: New Biomarkers of Exposure and Effects
CLINICAL_TRIALS study record update · 2025-12-19
A Phase 1 Study in Patients With Hematological Malignancies to Evaluate Safety, Tolerability and Efficacy of Karonudib
CLINICAL_TRIALS study record update · 2025-12-18
Bone Marrow Grafting for Leukemia and Lymphoma
CLINICAL_TRIALS study record update · 2025-12-15
Pediatric and Young Adult Leukemia Adoptive Therapy (PLAT)-05: A Phase 1 Feasibility and Safety Study of Dual Specificity CD19 and CD22 CAR-T Cell Immunotherapy for CD19+CD22+ Leukemia
CLINICAL_TRIALS study record update · 2025-12-15
A Pilot Study Evaluating Mosunetuzumab for Clearance of Detectable Minimal Residual Disease in Chronic Lymphocytic Leukemia
CLINICAL_TRIALS study record update · 2025-12-15
Early Versus Late Stopping of Antibiotics in Adults With High Risk Haematological Malignancies/Receiving Cellular Therapies and Fever (ELSA- Adult)
CLINICAL_TRIALS study record update · 2025-12-05
Prospective Data Collection Regarding Diagnosis, Treatment and Outcome of Adult ALL Patients and Related Diseases Associated With a Prospective Collection of Biomaterial
CLINICAL_TRIALS study record update · 2025-12-05
A Phase I/II Study of Neratinib in Pediatric Patients With Relapsed or Refractory Solid Tumors
CLINICAL_TRIALS study record update · 2025-12-04
A Phase 2, Multicenter, Randomized, Open-label Trial to Evaluate Safety and Efficacy of Two Dose Levels of Quizartinib as Maintenance for Adult Patients With Newly Diagnosed FLT3-ITD (+) Acute Myeloid Leukemia in Complete Remission
CLINICAL_TRIALS study record update · 2025-12-03
A Phase II Study of Thiotepa Added to Fludarabine and Melphalan as the Preparative Regime for Alternative Donor Transplantation
CLINICAL_TRIALS study record update · 2025-12-02
Efficacy on Progression Free Overall Survival of a Dose-Adjusted Regimen in Frail Adult Patients With Acute Lymphoblastic Leukemia
CLINICAL_TRIALS study record update · 2025-11-26
A Phase II Study to Evaluate Safety and Efficacy of CB-103 in Combination With Venetoclax in Adolescent and Young Adult Patients With Relapsed/Refractory T-cell Acute Lymphoblastic Leukemia (T-ALL)
CLINICAL_TRIALS study record update · 2025-11-26
Liquid Biopsy Evaluation and Repository Development at Princess Margaret